Clinical Study
Clinical Asthma Phenotypes and Therapeutic Responses
Table 5
Demographic data of patients that achieved control using treatment with either montelukast or fluticasone.
| Studied parameters | Controlled Cases Montelukast (%) | Controlled Cases Fluticasone (%) | |
| Age | | | | 10 Years | 88.8 | 30.3 | 0.006* | 10 Years |
11.2 | 69.7 | Sex | | | | Male | 13.3 | 41.6 | 0.005* | Female | 86.7 | 58.4 | Asthma-free days per week | 7 | 7 | | Asthma phenotypes | | | | Cough phenotype | 86 | 20 | 0.005* | SOB phenotype | 15 | 80 | Family history of asthma | | | | Positive | 88.8 | 25 | 0.006* | Negative | 11.2 | 75 | Body mass index (kg/m2) | | | | 20% | 100 | 75 | 0.333 | 20–25% | 0 | 8.4 | 25% | 0 | 16.6 | Duration | | | | 5 Years | 55.5 | 25 | | 5–10 Years | 33.3 | 58.4 | 0.006* | 10 Years | 11.2 | 16.6 | Eosinophilic% before treatment | | | | Mean + SD | 8.0 + 2.0 | 7 + 2.9 | 0.19 | Median | 8.0 | 6.0 |
|
|
significant <0.05.
|